Day Five of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Identifies Structural Variants that May Predispose to Severe COVID-19 Illness

COVID-19 Host Genome Structural Variant (SV) Consortium used Saphyr to identify SVs in severe COVID-19 patients that…

Tetra Bio-Pharma Files New Drug Submission for REDUVO(TM) in Canada

TSX:TBP |OTCQB:TBPMF Tetra Bio-Pharma announced today that the New Drug Submission (NDS) for the Dronabinol Soft…

Revive Therapeutics aims to file for an Emergency Use Authorization (“EUA”) of Bucillamine for mild to moderate COVID-19 with the FDA

RVV | RVVTF +21.06 yesterday Dec. 23, 2020, Revive Therapeutics announce an update on the Company’s…

Algernon Pharmaceuticals Announces Positive Trending Interim Data for its Phase 2b/3 Ifenprodil COVID Study

VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB:…

CytoDyn Announces First Patient Enrolled in Phase 2 Trial for NASH

Preclinical results demonstrated leronlimab effectively inhibited fatty liver development VANCOUVER, Washington, Dec. 02, 2020 (GLOBE NEWSWIRE)…

Sorrento Announces FDA IND Filing Today for COVI-GUARD Neutralizing and High Potency Antibody Against SARS-CoV-2

IND filing today for STI-1499 (COVI-GUARD™) for hospitalized COVID-19 patients. The initial trial is expected to…

FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex

– Age-range for all EPIDIOLEX indications expanded to include patients one year of age and older –…

ALERT COVID-19 | Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3

RVV | RVVTF TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the…

Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial

Algernon Pharmaceuticals Inc. (CSE: AGN) VANCOUVER, British Columbia, April 22, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE:…

WPD Pharmaceuticals and CNS Pharmaceuticals Announce Additional Coronavirus Testing on WP1122 by ImQuest Biosciences

WPD Pharmaceuticals Inc. (CSE: WBIO) VANCOUVER, British Columbia, April 21, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE:…

Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19

Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (CNSX:LXX.CN) Kelowna, British Columbia – TheNewswire – April 21, 2020 – Lexaria Bioscience Corp. (OTC:LXRP)…

ImmunoPrecise Provides Updates on B Cell Select™ and Deep Display™ Programs for SARS-CoV-2 Antibody Discovery

VICTORIA, April 17, 2020 /CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC QB:…